DMD and Duchenne muscular dystrophy: The systemic administration of AAV9-encoded CBE and sgRNA in neonatal DmdE4* mice not only leads to the highly efficient restoration of dystrophin protein in cardiac and skeletal muscles but also prevents the onset of DMD symptoms throughout the mouse lifespan [149].